Logo image of CTRI

CENTURI HOLDINGS INC (CTRI) Stock Fundamental Analysis

NYSE:CTRI - New York Stock Exchange, Inc. - US1559231055 - Common Stock - Currency: USD

18.58  -0.2 (-1.06%)

After market: 18.58 0 (0%)

Fundamental Rating

2

Overall CTRI gets a fundamental rating of 2 out of 10. We evaluated CTRI against 50 industry peers in the Construction & Engineering industry. CTRI may be in some trouble as it scores bad on both profitability and health. CTRI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CTRI had negative earnings in the past year.
In the past year CTRI had a positive cash flow from operations.
CTRI Yearly Net Income VS EBIT VS OCF VS FCFCTRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.32%, CTRI is doing worse than 64.00% of the companies in the same industry.
CTRI has a Return On Equity of -1.21%. This is in the lower half of the industry: CTRI underperforms 66.00% of its industry peers.
CTRI has a Return On Invested Capital (4.05%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CTRI is significantly below the industry average of 12.17%.
Industry RankSector Rank
ROA -0.32%
ROE -1.21%
ROIC 4.05%
ROA(3y)-5.23%
ROA(5y)N/A
ROE(3y)-42.36%
ROE(5y)N/A
ROIC(3y)4.36%
ROIC(5y)N/A
CTRI Yearly ROA, ROE, ROICCTRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

CTRI's Operating Margin of 3.29% is in line compared to the rest of the industry. CTRI outperforms 42.00% of its industry peers.
In the last couple of years the Operating Margin of CTRI has declined.
With a Gross Margin value of 8.37%, CTRI is not doing good in the industry: 72.00% of the companies in the same industry are doing better.
CTRI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.29%
PM (TTM) N/A
GM 8.37%
OM growth 3Y-6.01%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.56%
GM growth 5YN/A
CTRI Yearly Profit, Operating, Gross MarginsCTRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTRI is destroying value.
Compared to 1 year ago, CTRI has more shares outstanding
The debt/assets ratio for CTRI has been reduced compared to a year ago.
CTRI Yearly Shares OutstandingCTRI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
CTRI Yearly Total Debt VS Total AssetsCTRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CTRI has an Altman-Z score of 2.08. This is not the best score and indicates that CTRI is in the grey zone with still only limited risk for bankruptcy at the moment.
CTRI has a Altman-Z score (2.08) which is in line with its industry peers.
CTRI has a debt to FCF ratio of 15.25. This is a negative value and a sign of low solvency as CTRI would need 15.25 years to pay back of all of its debts.
CTRI has a Debt to FCF ratio of 15.25. This is in the lower half of the industry: CTRI underperforms 60.00% of its industry peers.
A Debt/Equity ratio of 1.55 is on the high side and indicates that CTRI has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.55, CTRI is doing worse than 72.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF 15.25
Altman-Z 2.08
ROIC/WACC0.42
WACC9.69%
CTRI Yearly LT Debt VS Equity VS FCFCTRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CTRI has a Current Ratio of 1.57. This is a normal value and indicates that CTRI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.57, CTRI is doing good in the industry, outperforming 78.00% of the companies in the same industry.
CTRI has a Quick Ratio of 1.57. This is a normal value and indicates that CTRI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CTRI (1.57) is better than 86.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.57
CTRI Yearly Current Assets VS Current LiabilitesCTRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.24% over the past year.
The Revenue has decreased by -9.04% in the past year.
CTRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.90% yearly.
EPS 1Y (TTM)96.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-9.04%
Revenue growth 3Y6.9%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

CTRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.71% yearly.
The Revenue is expected to grow by 3.54% on average over the next years.
EPS Next Y116.33%
EPS Next 2Y77.18%
EPS Next 3Y60.71%
EPS Next 5YN/A
Revenue Next Year3.55%
Revenue Next 2Y4.18%
Revenue Next 3Y3.54%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CTRI Yearly Revenue VS EstimatesCTRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CTRI Yearly EPS VS EstimatesCTRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CTRI. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 29.62, CTRI can be considered very expensive at the moment.
CTRI's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CTRI to the average of the S&P500 Index (20.81), we can say CTRI is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 29.62
CTRI Price Earnings VS Forward Price EarningsCTRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTRI is valued a bit cheaper than the industry average as 78.00% of the companies are valued more expensively.
CTRI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 27.93
EV/EBITDA 11.23
CTRI Per share dataCTRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

CTRI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTRI's earnings are expected to grow with 60.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.18%
EPS Next 3Y60.71%

0

5. Dividend

5.1 Amount

No dividends for CTRI!.
Industry RankSector Rank
Dividend Yield N/A

CENTURI HOLDINGS INC

NYSE:CTRI (5/2/2025, 8:04:01 PM)

After market: 18.58 0 (0%)

18.58

-0.2 (-1.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)05-07 2025-05-07/bmo
Inst Owners25.06%
Inst Owner Change-4.67%
Ins Owners0.2%
Ins Owner Change0.06%
Market Cap1.64B
Analysts75.38
Price Target21.32 (14.75%)
Short Float %22.84%
Short Ratio10.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-42.35%
Min EPS beat(2)-80.47%
Max EPS beat(2)-4.24%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.35%
Min Revenue beat(2)-7.13%
Max Revenue beat(2)4.44%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.43%
PT rev (3m)-5.36%
EPS NQ rev (1m)2%
EPS NQ rev (3m)-49.24%
EPS NY rev (1m)5.58%
EPS NY rev (3m)-9.18%
Revenue NQ rev (1m)-0.79%
Revenue NQ rev (3m)-3.16%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-0.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 29.62
P/S 0.62
P/FCF 27.93
P/OCF 10.39
P/B 2.96
P/tB N/A
EV/EBITDA 11.23
EPS(TTM)-0.08
EYN/A
EPS(NY)0.63
Fwd EY3.38%
FCF(TTM)0.67
FCFY3.58%
OCF(TTM)1.79
OCFY9.62%
SpS29.79
BVpS6.28
TBVpS-1.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.32%
ROE -1.21%
ROCE 5.13%
ROIC 4.05%
ROICexc 4.17%
ROICexgc 7.34%
OM 3.29%
PM (TTM) N/A
GM 8.37%
FCFM 2.23%
ROA(3y)-5.23%
ROA(5y)N/A
ROE(3y)-42.36%
ROE(5y)N/A
ROIC(3y)4.36%
ROIC(5y)N/A
ROICexc(3y)4.47%
ROICexc(5y)N/A
ROICexgc(3y)8.1%
ROICexgc(5y)N/A
ROCE(3y)5.52%
ROCE(5y)N/A
ROICexcg growth 3Y-0.39%
ROICexcg growth 5YN/A
ROICexc growth 3Y9.2%
ROICexc growth 5YN/A
OM growth 3Y-6.01%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.56%
GM growth 5YN/A
F-Score4
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF 15.25
Debt/EBITDA 3.87
Cap/Depr 73.39%
Cap/Sales 3.77%
Interest Coverage 1.11
Cash Conversion 71.23%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.57
Altman-Z 2.08
F-Score4
WACC9.69%
ROIC/WACC0.42
Cap/Depr(3y)76.71%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.05%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y116.33%
EPS Next 2Y77.18%
EPS Next 3Y60.71%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.04%
Revenue growth 3Y6.9%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year3.55%
Revenue Next 2Y4.18%
Revenue Next 3Y3.54%
Revenue Next 5YN/A
EBIT growth 1Y-36.39%
EBIT growth 3Y0.48%
EBIT growth 5YN/A
EBIT Next Year145.58%
EBIT Next 3Y45.64%
EBIT Next 5YN/A
FCF growth 1Y-3.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.51%
OCF growth 3Y13.06%
OCF growth 5YN/A